Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Urinary retention
ADR ID BADD_A04448
ADR Hierarchy
20      Renal and urinary disorders
20.02      Urinary tract signs and symptoms
20.02.02      Bladder and urethral symptoms
20.02.02.011      Urinary retention
Description A disorder characterized by accumulation of urine within the bladder because of the inability to urinate. [CTCAE] Inability to empty the URINARY BLADDER with voiding (URINATION). [MeSH]
MedDRA Code 10046555
MeSH ID D016055
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute retention | Acute retention of urine | Bladder inability to empty | Bladder retention | Chronic retention of urine | Feeling of residual urine | Incomplete bladder emptying | Incomplete urination | Other specified retention of urine | Retention of urine | Retention urinary | Retention urine | Retention with overflow | Urinary retention | Residual urine | Ischuria paradoxa | Paradoxical urinary retention | Unable to urinate | Urinary Retention | Retention, Urinary
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02381Ziconotide--
BADD_D02382Ziconotide acetate--
BADD_D02389Ziprasidone hydrochloride--
BADD_D02394Zolpidem--
BADD_D02395Zolpidem tartrate--
BADD_D02396Zonisamide0.000414%
BADD_D02398Zuclopenthixol--
BADD_D02412Octreotide0.000279%
BADD_D02432Glycopyrronium0.022696%
BADD_D02440Lisdexamfetamine--
BADD_D02442Magnesium oxide0.000365%
BADD_D02443Tiotropium0.001862%
BADD_D02445Solifenacin0.003282%
BADD_D02449Milnacipran0.000348%
BADD_D02456Vilazodone0.000479%
BADD_D02464Fingolimod0.007643%
BADD_D02465Aclidinium0.001085%
BADD_D02466Levomilnacipran0.000368%
BADD_D02468Cannabidiol0.002030%
BADD_D02470Nintedanib--
BADD_D02473Sodium chloride0.000362%
BADD_D02480Alectinib0.000112%
BADD_D02482Acalabrutinib0.000168%
BADD_D02490Apalutamide0.001902%
BADD_D02491Valbenazine0.011521%
BADD_D02505Gilteritinib0.000112%
BADD_D02507Deutetrabenazine0.000538%
BADD_D02511Siponimod0.000844%
BADD_D02520Baloxavir marboxil0.000282%
BADD_D02548Darolutamide0.000334%
The 16th Page    First    Pre   16 17    Next   Last    Total 17 Pages